Godavari Drugs Stock Screener | Share Price & Fundamental Analysis
GODAVARI
Pharmaceuticals
Screen Godavari Drugs share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹97.16
▲
15.59 (19.11%)
Market Cap
₹60.71 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.42
EPS (TTM)
₹5.82
Dividend Yield
-
Debt to Equity
1.48
52W High
₹112.75
52W Low
₹70.24
Operating Margin
10.00%
Profit Margin
3.77%
Revenue (TTM)
₹106.00
EBITDA
₹11.00
Net Income
₹4.00
Total Assets
₹143.00
Total Equity
₹43.00
Godavari Drugs Share Price History - Stock Screener Chart
Screen GODAVARI historical share price movements with interactive charts. Analyze price trends and patterns.
Godavari Drugs Company Profile - Fundamental Screener
Screen Godavari Drugs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GODAVARI shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE362C01012
Godavari Drugs Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen GODAVARI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 143 | 135 | 121 | 101 | 91 | 84 | 74 | 63 | 56 | 51 |
| Current Assets | 79 | 89 | 87 | 74 | 68 | 61 | 57 | 47 | 43 | 40 |
| Fixed Assets | 33 | 27 | 25 | 26 | 22 | 14 | 15 | 15 | 13 | 9 |
| Liabilities | ||||||||||
| Total Liabilities | 143 | 135 | 121 | 101 | 91 | 84 | 74 | 63 | 56 | 51 |
| Current Liabilities | 27 | 14 | 14 | 14 | 16 | 12 | 9 | 9 | 6 | 5 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 43 | 39 | 33 | 30 | 24 | 20 | 18 | 17 | 16 | 14 |
| Share Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves & Surplus | 36 | 31 | 26 | 22 | 17 | 13 | 11 | 10 | 9 | 7 |
Screen GODAVARI income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 106 | 114 | 157 | 160 | 161 | 123 | 96 | 84 | 65 | 76 | 71 | 55 |
| Expenses | 95 | 102 | 143 | 150 | 150 | 113 | 90 | 78 | 60 | 70 | 67 | 49 |
| EBITDA | 11 | 13 | 14 | 11 | 12 | 10 | 6 | 6 | 5 | 6 | 5 | 6 |
| Operating Profit % | 10.00% | 10.00% | 8.00% | 6.00% | 7.00% | 8.00% | 6.00% | 7.00% | 6.00% | 7.00% | 6.00% | 11.00% |
| Depreciation | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 4 | 5 | 5 | 4 | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 1 |
| Profit Before Tax | 5 | 6 | 7 | 5 | 7 | 6 | 2 | 2 | 1 | 3 | 2 | 5 |
| Tax | 1 | 1 | 1 | 1 | 2 | 2 | 0 | 1 | 1 | 1 | 1 | 1 |
| Net Profit | 4 | 4 | 6 | 4 | 5 | 4 | 2 | 1 | 1 | 2 | 1 | 4 |
| EPS | 4.90 | 5.82 | 7.37 | 5.03 | 6.97 | 5.48 | 2.66 | 1.60 | 1.10 | 2.40 | 1.79 | 4.84 |
Godavari Drugs Cash Flow Screener - Liquidity Fundamentals
Screen GODAVARI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 11 | 18 | 13 | 11 | 1 | 6 | 4 | 4 | 5 | -5 |
| Investing Activities | -20 | -13 | -9 | -5 | -1 | -7 | -2 | -3 | -3 | -2 |
| Financing Activities | 8 | -6 | -4 | -6 | 0 | 0 | -2 | 0 | -2 | 7 |
| Net Cash Flow | 0 | -1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
Screen GODAVARI shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 52.63% | 52.63% | 52.61% | 53.16% | 53.16% | 52.63% | 52.63% | 53.12% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 39.93% | 37.09% | 37.05% | 39.10% | 38.96% | 39.76% | 39.98% | 7.27% |
| Other Holding | 6.95% | 9.78% | 9.84% | 7.24% | 7.38% | 7.11% | 6.89% | 39.11% |
| Shareholder Count | 7,881 | 7,828 | 7,720 | 7,005 | 7,044 | 7,709 | 7,915 | 6,555 |
Godavari Drugs Dividend Screener - Share Yield Analysis
Screen GODAVARI dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Godavari Drugs Index Membership - Market Screener Classification
Screen GODAVARI by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Godavari Drugs Market Events Screener - Corporate Actions
Screen GODAVARI market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 4.77% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 0.47% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 4.42% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | -0.50% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -1.51% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -4.33% |
| 2024-08-29 | 2024-08-29 | Annual General Meeting | NA | 52.12% |
Godavari Drugs Competitors Screener - Peer Comparison
Screen GODAVARI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 423,939 | 40.53 | 54,729 | 9.71% | 10,980 | 49.55 |
| Divis Laboratories | 172,117 | 69.57 | 9,712 | 18.67% | 2,191 | 56.33 |
| Torrent Pharmaceuticals | 129,198 | 60.33 | 11,539 | 6.99% | 1,911 | 61.47 |
| Cipla | 121,825 | 22.48 | 28,410 | 7.12% | 5,291 | 49.47 |
| Dr Reddys Laboratories | 106,889 | 18.68 | 33,741 | 16.73% | 5,725 | 60.05 |
| Lupin | 96,553 | 22.34 | 22,910 | 13.74% | 3,306 | 65.28 |
| Zydus Life Science | 93,218 | 18.37 | 23,511 | 18.55% | 4,615 | 40.07 |
| Mankind Pharma | 91,921 | 50.91 | 12,744 | 20.90% | 2,007 | 45.53 |
| Aurobindo Pharma | 71,154 | 20.79 | 32,346 | 9.43% | 3,484 | 59.88 |
| Alkem Laboratories | 66,986 | 27.88 | 13,458 | 3.70% | 2,216 | 49.80 |
Godavari Drugs Company Announcements - News Screener
Screen GODAVARI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Unaudited Financials Results Pursuant To Regulation 33 Of The SEBI(LODR) Regulations 2015 For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-14 | Board Meeting Outcome for Unaudited Financial Statement For The Half-Year Ended 30Th September 2025 | View |
| 2025-11-07 | Board Meeting Intimation for Notice Of Board Meeting Scheduled To Be Held On Friday November 14 2025. | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-29 | Scrutinizers Report | View |
| 2025-09-29 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-27 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-19 | Closure of Trading Window | View |
| 2025-09-04 | Dispatch Of Letter To Shareholders | View |
| 2025-09-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-03 | Notice Of 37Th Annual General Meeting Of The Company | View |
| 2025-09-03 | Reg. 34 (1) Annual Report. | View |
| 2025-09-02 | Intimation Of Book Closure For The Purpose Of 37Th Annual General Meeting | View |
| 2025-09-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-13 | Shareholder Meeting / Postal Ballot - 37Th Annual General Meeting Scheduled On 27Th September 2025 | View |
| 2025-08-13 | Un-Audited Financial Results For The Period Ended 30.06.2025 | View |
| 2025-08-13 | Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th August 2025 | View |